Schwann Cell-Derived Exosomes Induced Axon Growth after Spinal Cord Injury by Decreasing PTP-σ Activation on CSPGs via the Rho/ROCK Pathway

• Published in: Neurochemical research Vol. 49; no. 8; pp. 2120 - 2130
• Main Authors: Zhu, Shibo, Ma, Hongpeng, Hou, Mengfan, Li, Hailiang, Ning, Guangzhi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.08.2024; Springer Nature B.V
• Subjects: Axon guidance; Biochemistry; Biomedical and Life Sciences; Biomedicine; Blood-brain barrier; Cell activation; Cell Biology; Chondroitin sulfate; Deposition; Exosomes; In vivo methods and tests; Neurochemistry; Neurology; Neuronal-glial interactions; Neurosciences; Original Paper; Protein-tyrosine-phosphatase; Proteoglycans; Recovery of function; Regeneration; Rocks; Signal transduction; Spinal cord injuries; Tyrosine; Spinal cord Injury; CSPGs; PTP-σ; Schwann cell; Exosome
• ISSN: 0364-3190; 1573-6903; 1573-6903
• DOI: 10.1007/s11064-024-04166-0

Spinal cord injury (SCI) is a severe neurological condition that involves a lengthy pathological process. This process leads to the upregulation of chondroitin sulfate proteoglycans (CSPGs) by reactive glia, which impedes repair and regeneration in the spinal cord. The role of the CSPG-specific receptor protein tyrosine phosphatase-sigma (PTP-σ) in post-SCI remains largely unexplored. Exosomes have great potential in the diagnosis, prognosis, and treatment of SCI due to their ability to easily cross the blood‒brain barrier. Schwann cell-derived exosomes (SCDEs) promote functional recovery in mice post-SCI by decreasing CSPG deposition. However, the mechanism by which SCDEs decrease CSPGs after SCI remains unknown. Herein, we observed elevated levels of PTP-σ and increased CSPG deposition during glial scar formation after SCI in vivo. After SCDEs were injected into SCI mice, CSPG deposition decreased in scar tissue at the injury site, the expression of PTP-σ increased during axonal growth around the injury site, and motor function subsequently recovered. Additionally, we demonstrated that the use of both Rho/ROCK inhibitors and SCDEs inhibited the reparative effects of SCDEs on scar tissue after SCI. In conclusion, our study revealed that treatment with SCDEs targeting the Rho/ROCK signaling pathway reduced PTP-σ activation in the CSPG post-SCI, which inhibited scar tissue formation.